NCT04446416 2026-04-09
Efficacy and Safety of NaviFUS System add-on Bevacizumab (BEV) in Recurrent GBM Patients
NaviFUS Corporation
Phase NA Completed
Clinical Trials
21 trialsNCT07272265 2025-12-09
The Effectiveness and Safety in High-risk Patients Receiving First-line Atezolizumab and Bevacizumab Combined With HAIC for HCC: a Retrospective Study
Sun Yat-sen University
Phase NA Completed
NCT02256800 2021-11-17
Escalated Dose of Irinotecan in mCRC
Kaohsiung Medical University Chung-Ho Memorial Hospital
Phase NA Completed
NCT02076152 2021-07-30
FMISO PET Study of Glioblastoma
Massachusetts General Hospital
Phase NA Completed
NCT01063283 2019-11-18
AVF4759
University of Chicago
Phase NA Completed
NCT00911716 2019-08-01
TC Avastin. ICORG 08-10, V6
Cancer Trials Ireland
Phase NA Completed
NCT00499694 2018-06-12
Satraplatin and Bevacizumab in Treating Patients With Metastatic Prostate Cancer Previously Treated With Docetaxel
Barbara Ann Karmanos Cancer Institute
Phase NA Completed
NCT01223235 2018-06-12
Polyvalent Vaccine-KLH Conjugate + Opt-821 Given in Combination With Bevacizumab
Memorial Sloan Kettering Cancer Center
Phase NA Completed
NCT01834014 2017-08-02
ATOM ES
EPS Corporation
Phase NA Completed
NCT00595322 2017-05-23
Bevacizumab in the Radiation Treatment of Recurrent Malignant Glioma
Memorial Sloan Kettering Cancer Center
Phase NA Completed
NCT01836536 2017-03-01
AVA-CELL
Center Eugene Marquis
Phase NA Completed
NCT00596362 2016-06-17
Treatment With Intravitreal Avastin for Large Uveal Melanomas
Memorial Sloan Kettering Cancer Center
Phase NA Completed
NCT00462501 2016-01-20
Combination Chemotherapy and Bevacizumab With or Without Radiation Therapy in Treating Patients With Locally Advanced Rectal Cancer
Memorial Sloan Kettering Cancer Center
Phase NA Completed
NCT00537901 2015-12-17
First-Line Bevacizumab and Chemotherapy in Metastatic Cancer of the Colon or Rectum - International Study
King Faisal Specialist Hospital & Research Center
Phase NA Completed
NCT00675597 2015-11-20
Docetaxel (Taxotere), Vinorelbine, and Bevacizumab, as Adjuvant Chemotherapy for Patients With Resected Stage I-III Non-small Cell Lung Cancer
Memorial Sloan Kettering Cancer Center
Phase NA Completed
NCT01405430 2015-06-29
AVECC
Centre Leon Berard
Phase NA Completed
NCT01017250 2014-02-28
Radiosurgery and Avastin for Recurrent Malignant Gliomas
Duke University
Phase NA Completed
NCT00121134 2013-12-24
Bevacizumab With or Without Cyclophosphamide and Methotrexate: A Pilot Study in Women With Operable Breast Cancer
Dana-Farber Cancer Institute
Phase NA Completed
NCT00602862 2013-12-02
Effect of Sorafenib on ccRCC Uptake of Radiolabeled Bevacizumab or cG250
Radboud University Medical Center
Phase NA Completed
NCT01125943 2013-01-10
Bevacizumab and Endothelium Dependent Vasodilation
Radboud University Medical Center
Phase NA Completed
NCT00929058 2010-05-18
BVZ1
Radboud University Medical Center
Phase NA Completed